Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells

J Neurochem. 2001 Aug;78(3):600-10. doi: 10.1046/j.1471-4159.2001.00438.x.

Abstract

Recent studies have provided evidence that Zn2+ plays a crucial role in ischemia- and seizure-induced neuronal death. However, the intracellular signaling pathways involved in Zn2+-induced cell death are largely unknown. In the present study, we investigated the roles of mitogen-activated protein kinases (MAPKs), such as c-Jun N-terminal kinase (JNK), p38 MAPK and extracellular signal-regulated kinase (ERK), and of reactive oxygen species (ROS) in Zn2+-induced cell death using differentiated PC12 cells. Intracellular accumulation of Zn2+ induced by the combined application of pyrithione (5 microM), a Zn2+ ionophore, and Zn2+ (10 microM) caused cell death and activated JNK and ERK, but not p38 MAPK. Preventing JNK activation by the expression of dominant negative SEK1 (SEKAL) did not attenuate Zn2+-induced cell death, whereas the inhibition of ERK with PD98059 and the expression of dominant negative Ras mutant (RasN17) significantly prevented cell death. Inhibition of protein kinase C (PKC) and phosphatidylinositol-3 kinase had little effect on Zn2+-induced ERK activation. Intracellular Zn2+ accumulation resulted in the generation of ROS, and antioxidants prevented both the ERK activation and the cell death induced by Zn2+. Therefore, we conclude that although Zn2+ activates JNK and ERK, only ERK contributes to Zn2+-induced cell death, and that ERK activation is mediated by ROS via the Ras/Raf/MEK/ERK signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • Antioxidants / pharmacology
  • Apoptosis / drug effects*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Immunoblotting
  • Indoles / pharmacology
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Signaling System / physiology
  • Maleimides / pharmacology
  • Microscopy, Fluorescence
  • Mitogen-Activated Protein Kinases / metabolism*
  • Neurons / cytology*
  • Neurons / drug effects
  • Neurons / metabolism
  • PC12 Cells
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Pyridines / pharmacology
  • Rats
  • Reactive Oxygen Species / metabolism*
  • Thiones
  • Time Factors
  • Transfection
  • Zinc / pharmacology*
  • p38 Mitogen-Activated Protein Kinases
  • ras Proteins / metabolism

Substances

  • Antifungal Agents
  • Antioxidants
  • Enzyme Inhibitors
  • Flavonoids
  • Indoles
  • Maleimides
  • Phosphoinositide-3 Kinase Inhibitors
  • Pyridines
  • Reactive Oxygen Species
  • Thiones
  • pyrithione
  • Protein Kinase C
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • ras Proteins
  • Zinc
  • bisindolylmaleimide I
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one